ResearcherZhongnan Hospital of Wuhan UniversityNo recent work listed

Liang Shao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-9066-8503; OpenAlex author ID A5101710117. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: 1 paper

Papers 2

Curcumin enhances anti‑cancer efficacy of either gemcitabine or docetaxel on pancreatic cancer cells. Co-author DOI 10.3892/or.2020.7713 ↗
Synergistic effects of baicalein with gemcitabine or docetaxel on the proliferation, migration and apoptosis of pancreatic cancer cells. Last author DOI 10.3892/ijo.2017.4153 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Pan Liu · 2 shared papers, 2017–2020 · strength 0.18
- Paper Curcumin enhances anti‑cancer efficacy of either gemcitabine or docetaxel on pancreatic cancer cells. DOI 10.3892/or.2020.7713 ↗
- Paper Synergistic effects of baicalein with gemcitabine or docetaxel on the proliferation, migration and apoptosis of pancrea… DOI 10.3892/ijo.2017.4153 ↗
Xinyi Li · 1 shared paper, 2020 · strength 0.13
- Paper Curcumin enhances anti‑cancer efficacy of either gemcitabine or docetaxel on pancreatic cancer cells. DOI 10.3892/or.2020.7713 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.